IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: United States/Americas

Novozymes acquires industrial enzyme business from Iogen

8:43 AM MST | February 8, 2013 | —Deepti Ramesh

Novozymes says it will acquire Iogen Bio-Products, the industrial enzyme business of Iogen (Ottawa, ON), for C$67.5 million ($67.7 million) and potential earn-out payments of up to C$12.5 million. The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities, and know-how. The acquisition does not include the purchase of process technology assets that relate to Iogen’s second-generation biofuels business. The acquisition is expected to be completed by the end of this month. Iogen Bio-Products...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa